Sign in
4

Changes in Ownership

Calidi Biotherapeutics, Inc. Filed Acc 0001393825-23-000222

10% owner disposed of 500,000 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Hudson Bay Capital Management LP 10% owner 2023-09-12 Other disposition −500,000 $10.49 $5,245,000 0 I
Loading xslF345X05/primary_doc.xml…